The three-dimensional structure of TNF has been determined at 0.29 nm using the technique of X-ray crystallography. Published data on site-directed mutagenesis and antibody binding may now be assessed in the light of the structure, thus the links between structure and function for TNF may be addressed.
Introduction
The biological action of the cytokine tumour necrosis factor (TNF) is dependent on its interactions with other protein molecules such as cell surface receptors, inhibitors etc. These interactions are governed by the precise arrangement adopted within three dimensions by the amino acids of the linear polypeptide sequence (primary structure) on formation of the correctly folded tertiary structure. Thus in order to understand how the TNF molecule performs its biological function at the level of amino acid interactions, one must not only know the amino acid sequence but also the three dimensional structure.
The three dimensional structure of human TNF has been determined to a resolution of 0.29 nm by X-ray crystallography (Jones et al. 1989) and has been refined to a current R factor of 20.4% (on all data from 0.6 to 0.29 nm with no model for the solvent structure). We present here a brief summary of the general topology and structural characteristics of the TNF molecule followed by a discussion, in the light of the structure, of data published by other authors on site directed mutagenesis and antibody binding.
The structure
The overall shape of a single 157 amino acid subunit of the TNF trimer is wedge like with height 5.5 nm and maximum breadth 3.5 nm near the base. The mainchain topology is illustrated in Fig. 1A ; it is essentially a /8-sandwich structure formed by two antiparallel /3-pleated sheets. The mainchain fold conforms to that of the classic jelly roll motif (Richardson, 1981, Fig. IB) common in viral capsid proteins. The nomenclature adopted in Fig. 1 for the labels of the secondary structural units follows the established convention for the viral structures (Rossmann et al. 1983) .
The crystallographic data yield a measure o f the relative flexibility of the various parts of the structure. The /3-strands form a fairly inflexible scaffold; in particular the back /3-sheet is situated at the core of the trimer and consequently is particularly rigid, and the C terminus is embedded in the base of this secondary structural unit. As would be expected it is the loops which adorn the outer, solvent-accessible surface of the molecule which exhibit high levels of flexibility/mobility. The N terminus is highly flexible and as far as residue 10 is rather independent of the rest of the molecule. Overall there is a general decrease in rigidity as the core becomes more loosely packed in the upper half of the molecule.
Three TNF monomeric subunits associate non-covalently to form a compact, conical trimer of length 5.5 nm and maximum breadth 5.0 nm. The /3-strands of the three individual /5-sandwiches lie approximately parallel to the threefold axis. The interaction between subunits related by the threefold axis is through a simple edge-to-face packing of the /3-sandwich; the edge of the /3-sandwich consisting of strands F and G from one subunit lies across the back /3-sheet (GDIB) of a threefold-related subunit (see Fig. 2 ). This mode of packing produces an extremely tight association between the subunits. Thus the core of the trimer is completely inaccessible to solvent. Loss of solvent-accessible surface area may be equated to hydrophobic free energy gain: each 0.01 nm2 of accessible surface area removed from contact with water gives a free energy gain of approximately 25calm ol_1 (lcal=4.184 Joules) (Chothia, 1974) . The solvent accessible surface area buried for a single TNF subunit on formation of the trimer is over 20 nm2, the energetic equivalent of about 30 hydrogen bonds. The stability of the TNF trimer is placed in perspective if one considers that for a typical antibody antigen complex the epitope comprises a solvent-accessible area of some 7 to 8 nm2 (Tulip et al. 1989) . The overall distribution of residue types in the three dimensional structure of TNF echoes the general rule for proteins; namely the hydrophobic residues cluster in the core of the molecule whilst charged residues decorate the surface. Thus the core of the TNF /3-sandwich has the expected filling of tightly intercalating, large, apolar residues. The detailed distribution of residue types becomes particularly noteworthy in the region near the trimeric threefold axis. At the top of the trimer the interaction between subunits involves charged sidechains, towards the center it is mediated by polar sidechains and at the base by a patch of large apolar s. The threefold interaction at the heart of the trimer is produced by the edge-to-face packing of the aromatic rings from a nest of tyrosine residues (59, 119 and 151) centred on T yrll9. There is 28% sequence identity between sequences of TNF and lymphotoxin (Pennica et al. 1984) . The majority of the residues conserved between the amino acid sequences of TNF and Fig. 3 . Residues buried at the trimeric interface. The residues for a TNF monomer are represented by spheres, with area proportional to their loss of solvent-accessible area on the association of three such monomers to form a trimer. The view is onto the back /3-sheet. Residues which are absolutely conserved in all TNF and lymphotoxin sequences are stippled. Residues which maintain a particular class identity (e.g. large apolars) are striped. Variable residues remain blank.
lymphotoxin may be classified, on the basis of the TNF structure, as internal to the /3-sandwich or at the trimeric interface; the conservation of the residues which form the surface buried in trimer formation is illustrated in Fig. 3 . This conservation in lymphotoxin of residues which play a key structural role in TNF strongly implies the presence of the same /^-sandwich motif in the lymphotoxin monomer and preservation of the edge-to-face mode of trimeric association (Jones et al. 1990a ).
Structure/function relationship
For the three-dimensional structure of TNF a set of prominent, surface residues, mainly from the loops connecting the /3-strands of the /3-sandwich, form the antibody-accessible surface of the trimer (Jones et al. 19906) . It has been observed that antibodies raised against TNF from one species (e.g. human) do not crossreact with TNF from another species (e.g. mouse), despite a sequence identity in excess of 80 % and the ability of TNF to bind to the TNF receptors of other species (Fiers et al. 1987) . However, it is immediately obvious from the structure that the most sequence-variable regions o f the molecule correspond to the antibody-accessible surface loops. Thus the epitope for an antibody against TNF will always contain some residues which will vary between species thus abolishing antibody binding. This implies that the characteristics of the interaction between TNF and its receptors must somehow differ from those required for binding of an antibody to TNF.
Neutralising antibodies have so far been mapped in two regions of TNF, amino acids 1-15 (Socher et al. 1987) and an epitope involving Argl31 (Fiers et al. 1990 ). However, antibodies are rather blunt instruments when employed to probe the properties of the TNF molecule; the relative sizes of the TNF trimer (3x157 residues) and a single antibody Fab fragment (about 400 residues) are comparable. A rather more specific probe of the structure/function relationship is provided by site-directed mutagenesis. Fiers et al. (1990) report more than a thousand fold loss of biological activity on mutating serine 86 to phenylalanine. A double mutation of the two external arginines 31 and 32 to asparagine and threonine by Tsujimoto et al. (1987) also resulted in a dramatic loss of biological activity. Yamamoto et al. (1989) have shown that site-directed mutagenesis of histidine 15 may abolish biological activity; this residue is involved in stabilising the threefold interaction in a region close to residues 31-32 and, in terms of the trimer, adjacent to serine 86. In contrast, mutation of tryptophan residues 28 and 114 to phenylalanines does not markedly affect biological activity (Van Ostade et al. 1988 ) nor does changing histides 73 and 78 to glutamines (Yamamoto et al. 1989) . Finally Narachi et al. (1987) have disrupted the disulphide bridge between cysteines 69 and 101 without deleterious effects. This set of functionally tolerated mutations generally lies in the upper portion of the molecule.
In Fig. 4 the various pieces of evidence are combined in a schematic diagram of the trimer structure. From the results of site-directed mutagenesis a region of functional importance appears to be located at the interface between two subunits on the lower half of the trimer. Both neutralising antibodies could serve to block receptor binding throughout this general region by simple steric hindrance. In addition, Creasey et al. (1987) have reported that truncation of the N terminus by four or seven amino acids actually increases biological activity; this would be consistent with the extremely flexible/mobile N terminus causing a slight steric hindrance effect at a receptor site in the region of residues 15, 31-32 and 86. Thus current circumstantial evidence points to a receptor-binding site which involves the interface between two subunits in this region near the base of the TNF trimer.
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